- Report
- February 2022
- 40 Pages
China
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
France
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Germany
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Ireland
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Japan
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Russia
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
South Korea
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
United States
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Vietnam
From €1365EUR$1,500USD£1,160GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,049GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,049GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,049GBP
- Report
- November 2021
- 600 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- January 2023
- 359 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- August 2022
- 324 Pages
Global
From €2447EUR$2,688USD£2,078GBP
€3495EUR$3,840USD£2,969GBP
- Report
- May 2022
- 213 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP

Morphine is an analgesic drug used to treat moderate to severe pain. It is a member of the opioid family, and is derived from the opium poppy plant. Morphine is available in a variety of forms, including tablets, capsules, syrups, and injectable solutions. Morphine is often used in the treatment of cancer pain, post-operative pain, and chronic pain. It is also used to treat acute pain, such as that caused by a heart attack or stroke. Morphine is generally considered to be a safe and effective analgesic, but it can cause side effects such as nausea, vomiting, constipation, and drowsiness.
Morphine is available in both generic and brand-name formulations. Some of the major companies in the market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more